Sail BiomedicinesCambridge, Massachusetts, United States
0016: Pharmacology Analyses of Sail’s In Vivo hCD19 CAR-T Product Reveal Mechanistic Insights Underlying its Optimal Dose Efficiency Profile in Both Healthy Donors and SLE Patient Samples
Sunday, October 26, 202510:30 AM - 12:30 PM Central Time
Disclosure information not submitted.